SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095461
Filing Date
2024-08-12
Accepted
2024-08-12 16:18:12
Documents
52
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-20240630.htm   iXBRL 10-Q 1898288
2 EX-31.1 sprb-ex31_1.htm EX-31.1 16251
3 EX-31.2 sprb-ex31_2.htm EX-31.2 15193
4 EX-32.1 sprb-ex32_1.htm EX-32.1 7921
5 EX-32.2 sprb-ex32_2.htm EX-32.2 8034
  Complete submission text file 0000950170-24-095461.txt   5821797

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20240630.xsd EX-101.SCH 881621
54 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20240630_htm.xml XML 607685
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 241197035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)